SEARCH

SEARCH BY CITATION

References

  • 1
    Stichting Farmaceutische Kengetallen [Pharmaceutical Indicators Foundation]. Data & Feiten [Data and Facts]. 2005. Available from http://www.sfk.nl/publicaties/2005denf (accessed 1 February 2008).
  • 2
    Zandstra S. M., Furer J. W., Van de Lisdonk E. H., Van't Hof M., Bor J. H. J., Van Weel C. et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 13944.
  • 3
    College voor Zorgverzekeringen [Dutch College for Health Care Insurance]. Gebruik van benzodiazepinen 1993– 1998 [Use of Benzodiazepines 1993–1998]. 2000. Available from http://www.cvz.nl/resources/GIPsignaal_1_benzodiazepinen_tcm28-16620.pdf (accessed 1 February 2008).
  • 4
    Holbrook A. M., Cheng C., King D., Crowther R., Lotter A. Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 2000; 162: 22533.
  • 5
    Holbrook A. M., Cheng C., King D., Crowther R., Lotter A. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. Can Med Assoc J 2000; 162: 21620.
  • 6
    Kupfer D. J., Reynolds C. F. Management of insomnia. N Engl J Med 1997; 336: 3416.
  • 7
    Lader M. H. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 2000; 9: S399405.
  • 8
    Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 2006; 18: 24955.
  • 9
    Barker M. J., Greenwood K. M., Jackson M., Crowe S. F. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004; 19: 43754.
  • 10
    Gorgels W. J., Breteler M. H., Van de Lisdonk E. H., Oude Voshaar R. C., Mol A. J., Zitman F. G. Het langdurig gebruik van benzodiazepinen [Long-term use of benzodiazepines]. Ned Tijdschr Geneeskd 2001; 145: 13426.
  • 11
    O'Connor K. P., Marchand A., Bélanger L., Mainguy N., Landry P., Savard P. et al. Psychological distress and adaptational problems associated with benzodiazepine withdrawal and outcome: a replication. Addict Behav 2004; 29: 58393.
  • 12
    Salzman C. Addiction to benzodiazepines. Psychiatr Q 1999; 69: 25161.
  • 13
    Schweizer E., Rickels K., De Martinis N., Case G., Garcia Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine-dependent patients. Psychol Med 1998; 28: 71320.
  • 14
    Wan H., Koder T. J., Cho K., Park Y., Warburton E. C., Zhu X. O. et al. Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory. Eur J Neurosci 2004; 20: 221424.
  • 15
    Westra H. A., Stewart S. H., Teehan M., Johl K., Dozois D. J., Hill T. Benzodiazepine use associated with decreased memory for psychoeducation material in cognitive behavioral therapy for panic disorder. Cogn Ther Res 2004; 28: 193.
  • 16
    Kan C. C., Breteler M. H., Zitman F. G. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand 1997; 96: 8593.
  • 17
    Oude Voshaar R. C., Gorgels W. J. M. J., Mol A. J. J., Couvée J. E., Van Balkom A. J. L. M., Zitman F. G. Behandelmethoden om langdurig benzodiazepinegebruik te staken [Treatment modalities to discontinue long-term benzodiazepine use]. Ned Tijdschr Geneeskd 2001; 137: 134750.
  • 18
    Terzano M. G., Ferini-Strambi L., Mondini S., Parrino L., Cirignotta F. Studio Morfeo 2: survey on the management of insomnia by Italian general practitioners. Sleep Med 2006; 7: 599606.
  • 19
    Ten Wolde G. B. Nog veel ruimte voor verbetering—voorlichting over benzodiazepinen [A lot to improve—education on benzodiazepines]. Pharm Weekblad 2004; 139: 14946.
  • 20
    Parr J. M., Kavanagh D. J., Young R. M., McCafferty K. Views of general practitioners and benzodiazepine users on benzodiazepines: a qualitative analysis. Soc Sci Med 2006; 62: 123749.
  • 21
    Brook O., Van Hout H., Nieuwenhuyse H., Heerdink E. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol 2003; 13: 19.
  • 22
    Kapur N., Appleton K., Neal R. D. Sources of job satisfaction and psychological distress in GPs and medical house officers. Fam Pract 2000; 16: 6001.
  • 23
    Blendon R. J., Schoen C., Donelan Robin Osborn K., DesRoches C. M., Scoles K., Davis K. et al. Physicians' views on Quality of Care: A Five-Country Comparison. Based on Commonwealth Fund 2000 International Health Policy Survey of Physicians. New York: The Commonwealth Fund; 2001.
  • 24
    Dempsey O. P., Moore H. Psychotropic prescribing for older people in residential care in the UK. Are guidelines being followed? Primary Care Psychiatry 2005; 10: 1318.
  • 25
    Brug J., Kok G., Van Breukelen G. J., Glanz K., Van Assema P. The impact of computer-tailored feedback and iterative feedback on fat, fruit, and vegetable intake. Health Educ Behav 1998; 25: 51731.
  • 26
    Kroeze W., Brug J., Werkman A. A systematic review of randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med 2006; 31: 20523.
  • 27
    Oenema A., Tan F., Brug J. Short-term efficacy of a web-based computer-tailored nutrition intervention: main effects and mediators. Ann Behav Med 2005; 29: 5463.
  • 28
    Dijkstra A., De Vries H., Roijackers J. Long-term effectiveness of computer-generated tailored feedback in smoking cessation. Health Educ Res 1998; 13: 20714.
  • 29
    Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Upper Saddle River, NJ: Prentice Hall, Inc.; 1986.
  • 30
    Dijkstra A., De Vries H. The development of computer-generated tailored interventions. Patient Educ Couns 2003; 36: 193203.
  • 31
    Oude Voshaar R., Van Balkom A., Mulder J., Breteler M., Gorgels W., Mol A. et al. Predictors of relapse after discontinuation of long-term benzodiazepine use by minimal intervention: a 2-year follow-up study. Fam Pract 2003; 20: 3702.
  • 32
    Gorgels W. J. M. J., Oude Voshaar R. C., Mol A. J. J., Van de Lisdonk E. H., Van Balkom A. J. L. M., Van den Hoogen H. J. M. et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend 2005; 78: 4956.
  • 33
    Velicer W. F., Prochaska J. O., Rossi J. S., Snow M. G. Assessing outcome in smoking cessation studies. Psychol Bull 1992; 111: 2341.
  • 34
    Zitman F. G., Couvée J. E. Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group. Br J Psychiatry 2001; 178: 31724.
  • 35
    Heyting A., Tolboom J. T., Essers J. G. Statistical handling of drop-outs in longitudinal clinical trials. Stat Med 1993; 11: 204361.
  • 36
    Miller W. R., Rollnick S. Motivational Interviewing. New York: Guilford Press; 1991.
  • 37
    Prochaska J. O., DiClemente C. C., Norcross J. C. In search of how people change: applications to addictive behaviors. Am Psychol 1992; 47: 110214.
  • 38
    Kazdin A. E. The evaluation of psychotherapy: research designs and methodology. In: GarfieldS. L., BerginA. E., editors. Handbook of Psychotherapy and Behavior Change. New York: John Wiley & Sons; 1986, p. 2368.